Most Popular Stories
Featured Jobs
-
Nurse Practitioner or Physician Assistant - ER 590
AVA Search Group - Middletown, OH -
Occupational Therapist
Makro Health - Manassas, VA -
NP or PA Job for Tennessee
StaffPointe, LLC - central, TN -
Psychiatry Job in Wisconsin
StaffPointe, LLC - near Wausau, WI -
Medical Technologist – Laboratory
Makro Health - Pecos, TX
Events
- Harvard Business School 7th Healthcare Conference
January 30, 2010
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Women in Health IT | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Electronic Medical Records (EMRs)
- Food and Drug Administration (FDA)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- health reform
- prescription drugs
- pharmaceutical companies
ALSO NOTED: MN Gov. withdraws healthcare promise; Cancer patients take front line in early-stage trials; and much more...
> Minnesota Gov. Tim Pawlenty withdrew promised support for a bill designed to cut healthcare spending by nearly 20 percent by 2015, citing a lack of support from Republican House members. Article
> Frustrated by the long years of research needed to prove the effectiveness of a new cancer therapy, British officials have designated a network of 19 hospital units that will be allowed to administer early-stage experimental cancer drugs to terminal patients. Report
> Big Pharma companies often are quick to turn their backs on a drug that doesn't deliver strong data. But a series of these failed development programs have been resurrected by scientists who decided to search for the kind of genetic biomarkers that would define a group of patients who would respond positively. Report
And Finally... Babies born prematurely may suffer the health consequences all the way through to adulthood. Report
Related Stories
- Avandia slammed by more studies
- VA removes Avandia from its formulary
- Study:Many MDs won't see sales reps
- Merck agrees to pay$650M+ to settle suits
- ALSO NOTED: Consolidation in the medical tourism biz; LA county closing clinics; and much more...
- Studies raise questions about how much drug safety info should be released
- Data providers challenge prescription-privacy laws
- Pharma hornet's nest keeps buzzing
- Medicare's needy struggle to get drugs
- Vaccine development surges
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





